Breaking

Public HealthFood Insecurity and Mental Health in South Africa Linked in New Survey ● Public HealthDirect-to-Consumer Microbiome Tests Face Regulatory Gaps, Review Finds ● PsychiatryREACH+ trial tests relapse prevention strategies in anorexia nervosa ● Medical InformaticsAToP framework maps EHR Transformer readmission risk to temporal patterns ● Public HealthFemale Health Volunteers in Nepal Show Readiness for Tobacco Cessation Counseling ● HematologyUganda study finds high antifolate resistance in children with sickle cell anaemia ● Infectious DiseaseSMC Sentinel Surveillance Detects Gaps and Emerging Resistance in Northern Kenya ● GeneticsIndirect Genetic Effects in ADHD and ASD Traits Across Development ●

Public HealthFood Insecurity and Mental Health in South Africa Linked in New Survey ● Public HealthDirect-to-Consumer Microbiome Tests Face Regulatory Gaps, Review Finds ● PsychiatryREACH+ trial tests relapse prevention strategies in anorexia nervosa ● Medical InformaticsAToP framework maps EHR Transformer readmission risk to temporal patterns ● Public HealthFemale Health Volunteers in Nepal Show Readiness for Tobacco Cessation Counseling ● HematologyUganda study finds high antifolate resistance in children with sickle cell anaemia ● Infectious DiseaseSMC Sentinel Surveillance Detects Gaps and Emerging Resistance in Northern Kenya ● GeneticsIndirect Genetic Effects in ADHD and ASD Traits Across Development ●

Advertisement

Translational Medicine

Clinical evidence, research, and medical intelligence in Translational Medicine.

Advertisement

Translational Medicine · JNCI

Multi-omics precision medicine links biology to actionable care

A review outlines how multi-omics, AI, and foundation models could turn complex biology into clinically useful decisions across cancer and chronic disease.

By Dr. A. Nikhil Krishnan, MBBS · Oct 19, 2026 · 6 min read

Translational Medicine

Clinical evidence, research, and medical intelligence in Translational Medicine.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.

Advertisement

Most Read

Medicine World Foundation Alerts

Daily Clinical Dispatch

Receive peer-screened summaries across 17 clinical specialties delivered to your inbox every morning.

Trending Topics Clinical Keywords

#GLP-1 #Lecanemab #CAR-T #SepsisBundle #Semaglutide #SGLT2 #LongCOVID #AntibioticStewardship #AIDiagnostics #Statins

Advertisement

Advertisement